/compare — side-by-sideLOADING
Valuation, growth, margins and forensic scores side-by-side — computed from each company's own SEC filings and last EOD close. No estimates, no fluff.
| Metric | GRIGRI Bio, Inc. |
|---|---|
| Last close | $1.67 |
| Change % | -5.65% |
| Market cap | $4M |
| P/E | — |
| Revenue | $0 |
| Rev growth (YoY) | -100.0% |
| Net income | $-11956000 |
| Net margin | — |
| EPS (diluted) | $-121.80 |
| Piotroski F-ScoreUNVALIDATED | 3 |
| Altman Z-ScoreUNVALIDATED | -5.66 |
| Beneish M-ScoreUNVALIDATED | — |
| Next earnings | 01-29 → 02-08 |
Fundamentals from XBRL company facts (as filed); market cap & P/E use last EOD close. Green = best in the row among the compared names. Educational only — not investment advice.